← Open Payments lookup

AMY RUDDICK: Open Payments

NPI 1013581685 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,307 in 117 payments from 15 companies in 2025. Trend: 2023 $3,032 · 2024 $2,617 · 2025 $2,307

Food & beverage: $2,223Education: $84
CompanyPaymentsAmount
ABBVIE INC.41$738
Madrigal Pharmaceuticals15$243
Janssen Biotech, Inc.8$218
Gilead Sciences, Inc.11$202
Takeda Pharmaceuticals U.S.A., Inc.9$192
GENZYME CORPORATION5$152
Ipsen Biopharmaceuticals, Inc6$135
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$104
Celltrion USA Inc.4$67
Lilly USA, LLC3$66

Products named: CREON, REZDIFFRA, RINVOQ, TREMFYA, DUPIXENT, LINZESS, IQIRVO, ENTYVIO.

Industry payments across NE — which companies pay providers there.